ADMA Biologics Inc

28 sie 2026, 20:07 UTC

ADMA Biologics Inc shares are lower today, continuing a three-day decline. The stock remains significantly below its 20-day moving average amid rising Treasury yields.

27 sie 2026, 19:11 UTC

ADMA Biologics Inc. shares are lower today amid pressure on biotechnology stocks, despite a brief uptick earlier in the session. No specific news was identified.

26 sie 2026, 20:08 UTC

ADMA Biologics Inc. shares are lower amid biotechnology sector weakness, with no specific news identified to explain the decline.

25 sie 2026, 19:26 UTC

ADMA Biologics shares are higher today, supported by declining U.S. Treasury yields that typically enhance equity valuations. No specific company news was identified.

24 sie 2026, 20:06 UTC

ADMA Biologics Inc shares are lower during Monday's session, reversing earlier gains amid broader market influences, including rising oil prices and geopolitical tensions.

21 sie 2026, 23:01 UTC

ADMA Biologics Inc shares declined in after-market trading, continuing a trend of lower finishes over the past three sessions amid broader market volatility.

20 sie 2026, 20:06 UTC

ADMA Biologics Inc shares are lower in Thursday's session, with no specific news identified. Broader market declines may be influencing sentiment amid rising Treasury yields.

19 sie 2026, 20:01 UTC

ADMA Biologics Inc shares are higher Wednesday, continuing a strong upward trend since Tuesday's close, despite no specific news driving the move.

17 sie 2026, 19:36 UTC

ADMA Biologics is trading lower amid an investigation into potential fiduciary breaches by its Board of Directors. Broader market sentiment may also be impacting shares.

13 sie 2026, 20:02 UTC

ADMA Biologics shares are lower amid concerns over financial practices and potential SEC scrutiny, despite claims of an internal review clearing the company.

12 sie 2026, 19:46 UTC

ADMA Biologics shares are trading lower today, despite broader market gains following a positive inflation report. The stock remains near its one-month high.

11 sie 2026, 22:56 UTC

ADMA Biologics Inc shares are lower in after-market hours following an earlier decline. The price remains above its 20-day moving average.

7 sie 2026, 19:46 UTC

ADMA Biologics shares are lower following a securities fraud class action lawsuit alleging false statements and undisclosed transactions, amid broader negative market sentiment.

6 sie 2026, 20:02 UTC

ADMA Biologics reported second-quarter net income of $37.82 million and revenue of $124.40 million, driving shares higher during Thursday's session.

5 sie 2026, 23:02 UTC

ADMA Biologics reported second-quarter revenue of $124.4 million, missing expectations. Shares are lower in after-market trading following the earnings release.

4 sie 2026, 19:46 UTC

ADMA Biologics Inc. is trading higher, buoyed by strong momentum and a decline in crude oil prices that eases inflation concerns and supports consumer spending.

3 sie 2026, 19:16 UTC

ADMA Biologics Inc shares are higher today, continuing an upward trend since Friday amid broader market optimism following recent geopolitical developments.

31 lip 2026, 20:06 UTC

ADMA Biologics is declining amid a class action lawsuit alleging fraudulent activities, continuing a trend of four consecutive lower sessions.

30 lip 2026, 19:39 UTC

ADMA Biologics shares are lower following a decline in first-quarter performance, reflecting broader market sentiment amid ongoing investor concerns.

29 lip 2026, 18:17 UTC

ADMA Biologics will report second-quarter 2026 results on August 5, contributing to today's higher share price amid steady trading.

28 lip 2026, 20:06 UTC

ADMA Biologics Inc. is rising amid broader biotechnology sector strength, despite ongoing legal challenges. The stock has shown steady gains since Monday's close.

27 lip 2026, 19:41 UTC

ADMA Biologics Inc shares are higher today, continuing a strong performance since Friday. No specific news was identified to explain the gains.

24 lip 2026, 19:26 UTC

ADMA Biologics shares are lower amid a securities fraud lawsuit alleging inflated revenue growth and related party transactions, impacting investor sentiment.

22 lip 2026, 18:36 UTC

ADMA Biologics shares are lower as a class action lawsuit targets investors, alleging false statements about business practices and internal controls.

21 lip 2026, 19:36 UTC

ADMA Biologics Inc faces a class action lawsuit alleging securities fraud, contributing to its decline since Monday's close. Shares briefly rebounded earlier in the session.

20 lip 2026, 19:46 UTC

ADMA Biologics Inc shares are higher during Monday's session, despite fluctuations and no specific news to explain the price action since Friday's close.